Intramuscular delivery of DNA releasing microspheres: microsphere properties and transgene expression

Journal of Controlled Release : Official Journal of the Controlled Release Society
Jae-Hyung Jang, Lonnie D Shea

Abstract

Plasmid-loaded microspheres can provide localized and sustained release into the target tissue, and thus have the potential to enhance the efficiency of naked DNA at promoting transgene expression. In this report, microsphere design parameters are investigated by correlating the extent and duration of transgene expression intramuscularly to the polymer molecular weight and the mass of DNA delivered. Plasmid DNA was incorporated into poly (lactide-co-glycolide) microspheres using a cryogenic double emulsion process, and microspheres were injected intramuscularly. Bolus injection of naked plasmid was used for control, which exhibited transfection of muscle cells with transgene expression that gradually decreased over time. Microspheres fabricated from low molecular weight polymer had expression levels that increased from day 1 to day 92, which subsequently decreased through day 174. Decreasing the microsphere mass delivered resulted in steady expression during the same time. However, microspheres fabricated with high molecular weight polymer had expression for only 14 days. Intramuscular injection resulted in a foreign body response to the microspheres, and these infiltrating cells adjacent were primarily transfected. This unders...Continue Reading

References

Mar 23, 1990·Science·J A WolffP L Felgner
Jul 4, 1986·Cell·H WeintraubK Conrad
Oct 1, 1996·Pharmaceutical Development and Technology·G A BrazeauE Fattal
Aug 28, 1998·Human Gene Therapy·V L Truong-LeK W Leong
Apr 1, 1999·Journal of Controlled Release : Official Journal of the Controlled Release Society·S M ButlerR D Tilton
Apr 14, 1999·Proceedings of the National Academy of Sciences of the United States of America·L M MirD Scherman
May 26, 1999·Proceedings of the National Academy of Sciences of the United States of America·G RizzutoE Fattori
Jul 8, 1999·Biomaterials·C E HolyM S Shoichet
Jan 19, 2000·Proceedings of the National Academy of Sciences of the United States of America·M SinghD O'Hagan
Mar 20, 2001·Journal of Biomedical Materials Research·J J Yoon, T G Park
Dec 20, 2002·Journal of Controlled Release : Official Journal of the Controlled Release Society·G García del BarrioJ M Irache
Dec 20, 2002·Journal of Controlled Release : Official Journal of the Controlled Release Society·Lea Ann DaileyThomas Kissel
Jun 18, 2003·Journal of Controlled Release : Official Journal of the Controlled Release Society·Toshihiro KushibikiYasuhiko Tabata
Feb 26, 2004·Journal of Controlled Release : Official Journal of the Controlled Release Society·Dan LuoW Mark Saltzman
Jul 6, 2004·Immunological Reviews·Derek T O'HaganJeffrey B Ulmer
Jul 9, 2004·The Journal of Gene Medicine·Anne-Cécile DurieuxDamien Freyssenet
Aug 18, 2004·Journal of Controlled Release : Official Journal of the Controlled Release Society·Zhenhua Li, Leaf Huang
Sep 24, 2004·Journal of Controlled Release : Official Journal of the Controlled Release Society·Iosif Daniel RoscaMotohiro Uo
Nov 30, 2004·Journal of Controlled Release : Official Journal of the Controlled Release Society·Miechel L T ZweersJan Feijen
May 24, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·C G OsterT Kissel
Jun 14, 2005·Molecular Therapy : the Journal of the American Society of Gene Therapy·Jae-Hyung JangLonnie D Shea
Sep 6, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·F Kurtis KasperYasuhiko Tabata

❮ Previous
Next ❯

Citations

Dec 4, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Laura De LaporteLonnie D Shea
Feb 21, 2014·Veterinary Research·Linn B HølvoldRoy A Dalmo
Oct 12, 2007·Journal of Controlled Release : Official Journal of the Controlled Release Society·Neelesh K Varde, Daniel W Pack
Sep 29, 2007·Journal of Controlled Release : Official Journal of the Controlled Release Society·Hui-Li FuRen-Xi Zhuo
Mar 14, 2007·Vaccine·John R Greenland, Norman L Letvin
Jun 1, 2007·Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society·Sangeeta K CheemaAnshu B Mathur
Apr 22, 2009·Journal of Cellular and Molecular Medicine·Cristiano SpadaccioJorge A Genovese
Nov 30, 2011·Journal of Biomedical Materials Research. Part a·Dewi P GoAndrea J O'Connor
Apr 7, 2016·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Thaigarajan ParumasivamHak-Kim Chan
Sep 10, 2014·Journal of Biomedical Materials Research. Part a·Dewi P GoAndrea J O'Connor
Oct 6, 2009·Nanomedicine : Nanotechnology, Biology, and Medicine·Yen CuW Mark Saltzman
Oct 30, 2014·Langmuir : the ACS Journal of Surfaces and Colloids·Ciprian IliescuGuillaume Tresset
Dec 14, 2014·Journal of Materials Chemistry. B, Materials for Biology and Medicine·M A UrelloM O Sullivan
Feb 23, 2009·Advanced Materials·David N NguyenDaniel G Anderson
Dec 17, 2020·International Journal of Pharmaceutics·Jan KožákAlf Lamprecht

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.